What We're Reading: Page 112
Industry reads hand-picked by our editors
Feb 02, 2023
Feb 01, 2023
-
The New York Times
Vaccine Makers Kept $1.4 Billion in Prepayments for Canceled Covid Shots for the World’s Poor
-
CNBC
Google’s ex-CEO Eric Schmidt tapped for federal biotech commission that allows members to keep biotech investments
-
STAT
6 things to know about Apellis’ eye drug ahead of FDA decision
-
Evaluate Vantage
Novo still cannot meet Wegovy demand
Jan 31, 2023
Jan 30, 2023
Jan 27, 2023
-
Reuters
U.S. Senator Warren ‘particularly concerned’ about Amgen, Indivior deals
-
Financial Times
Big pharma groups rejoin battle with governments on drug prices
-
Evaluate Vantage
US regulator stays firm on knockbacks
-
Fierce Biotech
Early data from AC Immune Alzheimer’s vaccine suggests response
Previous
